Dr Michael Entzeroth

Dr. Michael Entzeroth is Managing Partner at ME Pharma Consult, Davao, Philippines and was until 31 December 2019 Chief Scientific Officer/Chief Operating Officer of Cennerv Pharma (S) Pte Ltd in Singapore, a company focused on the development of novel drugs for the treatment of central nervous diseases.

From 2007 to 2013, he was the Deputy Director and Vice President Research and Development and Deputy Director of the Experimental Therapeutic Centre, Biopolis, Singapore. Previously, he was Chief Scientific Officer of S*BIO Pte Ltd in Singapore and between 1999 and 2002, as Vice President of CEREP SA in France, he was a member of the Executive Management Committee.

From 1985 to 1999, with Boehringer Ingelheim, Germany, he was responsible for a variety of drug discovery programs. A number of drug candidates, he worked on during his career, are either on the market or in advanced clinical stage among them Micardis™, a blockbuster drug. Over the years, results from his work have been published in more than 50 publications in peer-reviewed scientific journals.